Marriott Harrison advises XTX Ventures on their Seed Investment into Lucida Medical Ltd

Thursday 25th March, 2021

The team at MH were delighted to advise XTX Ventures as they led the Seed Investment into Lucida Medical Ltd.

The multi-million-pound investment round included Prostate Cancer Research and a number of leading radiologists and urologists.

The company develops AI technology that finds cancer more accurately by analysing MRI, enabling radiologists to save time and patients to receive the best possible diagnosis and treatment. The funding will be used to extend the team, achieve regulatory approvals for the company’s technology, and complete a 2,000-patient clinical study.

The team at MH was led by David Strong and included David Bettis, Troy Featherstone, Ed Belam and Alex Lee.

Articles by David Strong